• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泼尼松龙治疗肾上腺皮质功能不全:相对效价的重新评估。

Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.

作者信息

Punthakee Zubin, Legault Laurent, Polychronakos Constantin

机构信息

Endocrinology and Metabolism, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.

出版信息

J Pediatr. 2003 Sep;143(3):402-5. doi: 10.1067/S0022-3476(03)00294-4.

DOI:10.1067/S0022-3476(03)00294-4
PMID:14517528
Abstract

Prednisolone has unknown growth-suppressing effects relative to other steroids. We retrospectively studied 9 children (6 with congenital adrenal hyperplasia, CAH) receiving hydrocortisone replacement after switching to prednisolone (dose ratio, 1:5). Growth velocity and, in patients with CAH, 17-OHP decreased significantly. Dose reduction reversed these effects. Roughly, growth suppression relative potency for prednisolone:hydrocortisone was 15:1.

摘要

相对于其他类固醇,泼尼松龙的生长抑制作用尚不清楚。我们回顾性研究了9名在改用泼尼松龙(剂量比为1:5)后接受氢化可的松替代治疗的儿童(6名患有先天性肾上腺皮质增生症,CAH)。生长速度以及CAH患者的17-OHP均显著下降。剂量减少可逆转这些影响。大致上,泼尼松龙与氢化可的松的生长抑制相对效力为15:1。

相似文献

1
Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.泼尼松龙治疗肾上腺皮质功能不全:相对效价的重新评估。
J Pediatr. 2003 Sep;143(3):402-5. doi: 10.1067/S0022-3476(03)00294-4.
2
Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia.氢化可的松混悬液和氢化可的松片剂在治疗先天性肾上腺皮质增生症儿童方面并非生物等效。
J Clin Endocrinol Metab. 2001 Jan;86(1):441-5. doi: 10.1210/jcem.86.1.7275.
3
A Prospective Study of Children Aged 0-8 Years with CAH and Adrenal Insufficiency Treated with Hydrocortisone Granules.一项针对接受氢化可的松颗粒治疗的 0-8 岁先天性肾上腺皮质增生症和肾上腺皮质功能减退症患儿的前瞻性研究。
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1433-e1440. doi: 10.1210/clinem/dgaa626.
4
Impact of hydrocortisone on adult height in congenital adrenal hyperplasia-the Minnesota cohort.先天性肾上腺皮质增生症中氢化可的松对成年身高的影响-明尼苏达队列研究。
J Pediatr. 2014 May;164(5):1141-1146.e1. doi: 10.1016/j.jpeds.2014.01.011. Epub 2014 Feb 20.
5
Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.肾上腺皮质功能不全和先天性肾上腺皮质增生患者的昼夜氢化可的松输注
Clin Endocrinol (Oxf). 2006 Jul;65(1):45-50. doi: 10.1111/j.1365-2265.2006.02544.x.
6
Follow-up of linear growth of body height in children with nephrotic syndrome.肾病综合征患儿身高线性增长的随访
J Microbiol Immunol Infect. 2006 Oct;39(5):422-5.
7
Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.氟他胺、睾酮内酯和降低的氢化可的松剂量可维持先天性肾上腺皮质增生症患儿的正常生长速度和骨骼成熟,尽管其雄激素水平升高。
J Clin Endocrinol Metab. 2000 Mar;85(3):1114-20. doi: 10.1210/jcem.85.3.6462.
8
High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone.静脉注射免疫球蛋白加泼尼松龙治疗的川崎病患儿肾上腺抑制的高发生率。
Endocr J. 2015;62(2):145-51. doi: 10.1507/endocrj.EJ14-0385. Epub 2014 Oct 22.
9
Effect of the dose of oral hydrocortisone on growth rate during long-term treatment of children with salt losing congenital adrenal hyperplasia.口服氢化可的松剂量对失盐型先天性肾上腺皮质增生症患儿长期治疗期间生长速率的影响
Medicina (B Aires). 2002;62(6):551-4.
10
Mortality Risk in Patients With Adrenal Insufficiency Using Prednisolone or Hydrocortisone: A Retrospective Cohort Study.使用泼尼松龙或氢化可的松治疗肾上腺功能不全患者的死亡率风险:一项回顾性队列研究。
J Clin Endocrinol Metab. 2021 Jul 13;106(8):2242-2251. doi: 10.1210/clinem/dgab347.

引用本文的文献

1
Commentary: Postoperative hypothalamic-pituitary dysfunction and long-term hormone replacement in patients with childhood-onset craniopharyngioma.评论:儿童期颅咽管瘤患者术后下丘脑-垂体功能障碍及长期激素替代治疗
Front Endocrinol (Lausanne). 2024 Feb 27;15:1371424. doi: 10.3389/fendo.2024.1371424. eCollection 2024.
2
Practice Variation among Pediatric Endocrinologists in the Dosing of Glucocorticoids in Young Children with Congenital Adrenal Hyperplasia.小儿内分泌科医生在先天性肾上腺皮质增生症幼儿糖皮质激素给药方面的实践差异
Children (Basel). 2023 Nov 29;10(12):1871. doi: 10.3390/children10121871.
3
Clinical Update on Congenital Adrenal Hyperplasia: Recommendations from a Multidisciplinary Adrenal Program.
先天性肾上腺增生症的临床最新进展:多学科肾上腺项目的建议
J Clin Med. 2023 Apr 26;12(9):3128. doi: 10.3390/jcm12093128.
4
Two siblings with non-classic P450scc deficiency resulted from a novel mutation in gene misdiagnosed as familial glucocorticoid deficiency.两名患有非典型 P450scc 缺陷的兄弟姐妹,因基因中的一个新突变而导致,最初误诊为家族性糖皮质激素缺乏症。
BMJ Case Rep. 2022 Dec 8;15(12):e250238. doi: 10.1136/bcr-2022-250238.
5
Challenges in treatment of patients with non-classic congenital adrenal hyperplasia.非经典型先天性肾上腺皮质增生症患者治疗的挑战。
Front Endocrinol (Lausanne). 2022 Dec 12;13:1064024. doi: 10.3389/fendo.2022.1064024. eCollection 2022.
6
Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision).21-羟化酶缺乏症诊断与治疗临床指南(2021年修订版)
Clin Pediatr Endocrinol. 2022;31(3):116-143. doi: 10.1297/cpe.2022-0009. Epub 2022 Apr 10.
7
Quality of Life and its Determinants in Patients With Adrenal Insufficiency: A Survey Study at 3 Centers in the United States.肾上腺功能减退症患者的生活质量及其决定因素:美国 3 个中心的调查研究。
J Clin Endocrinol Metab. 2022 Jun 16;107(7):e2851-e2861. doi: 10.1210/clinem/dgac175.
8
The Impact of the COVID-19 Pandemic on Self-Reported Outcomes in Patients With Adrenal Insufficiency.COVID-19 大流行对肾上腺功能不全患者自我报告结局的影响。
J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2469-e2479. doi: 10.1210/clinem/dgab334.
9
Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.先天性肾上腺皮质增生症-病理生理学、诊断和治疗的最新见解。
Endocr Rev. 2022 Jan 12;43(1):91-159. doi: 10.1210/endrev/bnab016.
10
Hydrocortisone dosing in children with classic congenital adrenal hyperplasia: results of the German/Austrian registry.经典型先天性肾上腺皮质增生症患儿的氢化可的松给药:德国/奥地利登记研究结果
Endocr Connect. 2021 May 19;10(5):561-569. doi: 10.1530/EC-21-0023.